Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
about
Surgical management and outcome of spinal alveolar soft part sarcoma (ASPA): a case series of five patients and literature review.Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press.
P2860
Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Validation and utilization of ...... nd alveolar soft part sarcoma.
@ast
Validation and utilization of ...... nd alveolar soft part sarcoma.
@en
type
label
Validation and utilization of ...... nd alveolar soft part sarcoma.
@ast
Validation and utilization of ...... nd alveolar soft part sarcoma.
@en
prefLabel
Validation and utilization of ...... nd alveolar soft part sarcoma.
@ast
Validation and utilization of ...... nd alveolar soft part sarcoma.
@en
P2093
P2860
P1433
P1476
Validation and utilization of ...... and alveolar soft part sarcoma
@en
P2093
Alyssa L Mahaffey
Anil V Parwani
Gabriela Quiroga-Garza
Kathleen Cieply
Rajiv Dhir
Sheldon Bastacky
P2860
P2888
P356
10.1186/S13000-015-0412-Z
P577
2015-09-29T00:00:00Z
P5875
P6179
1014427141